Remisol Advance running on hardware with Windows XP, Windows 7, Windows Server 2003 and Windows Server 2008 operating systems
Publicado el 11 de marzo de 2020 · Inicio del retiro: 15 de agosto de 2019
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
A patch was released for a critical remote code execution vulnerability in remote desktop services. This vulnerability can be exploited remotely without authentication on certain operating systems. An attacker who successfully exploited this vulnerability could execute arbitrary code on the target system; then install programs; view, change, or delete data; or create new accounts with full user rights. If the vulnerability could be exploited locally, it would lock down the computer.
Qué hacer
Voluntary: Firm initiated · Letter
Detalles del retiro
- Fabricante
- Normand-Info S.A.S.U.
- Distribuidor
- U.S.: NY, AZ, FL, NJ, MA, OH, CA, IL, NC, OK, IN, KY, OR, MI, WI, PA, UT, GA, VA, TX, NE, SD, IA, MN, MD, DE, SC, MT, WV, LA, MO, TN, NM, NV, HI, WA, WY, AL, AR, MS, RI, ID, ME, DC, ND, AK, CO, CT, KS, NH, VT
- Lote
- All serial numbers
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- France
¿Vendes productos como este?
Recalert vigila todo tu catálogo contra retiros como este, automáticamente.